News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,761 Results
Type
Article (39686)
Company Profile (247)
Press Release (658828)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204165)
Career Advice (2007)
Deals (35419)
Drug Delivery (95)
Drug Development (81044)
Employer Resources (172)
FDA (16180)
Job Trends (14857)
News (345182)
Policy (32536)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49431)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (124)
Approvals (16185)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2253)
Cardiovascular disease (174)
Career advice (1676)
Career pathing (30)
CAR-T (150)
Cell therapy (421)
Cervical cancer (19)
Clinical research (65980)
Collaboration (832)
Compensation (529)
Complete response letters (19)
COVID-19 (2588)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2199)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6368)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86618)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112380)
Executive appointments (722)
FDA (17436)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (707)
Government (4415)
Grass and pollen (4)
Guidances (65)
Healthcare (18815)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16509)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (67)
Medical device (13375)
Medtech (13380)
Mergers & acquisitions (19453)
Metabolic disorders (683)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1912)
NextGen: Class of 2025 (6513)
Non-profit (4480)
Now hiring (39)
Obesity (362)
Opinion (204)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57297)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20552)
Phase II (29055)
Phase III (21648)
Pipeline (1196)
Policy (138)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22277)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (29)
Vaccines (686)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (168)
Last 7 days (859)
Last 30 days (2623)
Last 365 days (32864)
2025 (10649)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54085)
2019 (46538)
2018 (35019)
2017 (32109)
2016 (31483)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37836)
Australia (6184)
California (6111)
Canada (2010)
China (522)
Colorado (265)
Connecticut (274)
Delaware (146)
Europe (81234)
Florida (910)
Georgia (206)
Idaho (57)
Illinois (534)
India (25)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (890)
Massachusetts (4560)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1724)
New Mexico (28)
New York (1743)
North Carolina (966)
North Dakota (8)
Northern California (2673)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1374)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2293)
Tennessee (101)
Texas (904)
United States (23065)
Utah (180)
Virginia (144)
Washington D.C. (61)
Washington State (550)
West Virginia (3)
Wisconsin (54)
698,761 Results for "medpace inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medpace Holdings, Inc. Reports First Quarter 2025 Results
April 22, 2025
·
17 min read
Press Releases
Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025
March 19, 2025
·
1 min read
Press Releases
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results
February 10, 2025
·
19 min read
Business
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
Medpace Holdings, Inc. announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024.
June 26, 2024
·
1 min read
Press Releases
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025
January 2, 2025
·
1 min read
Business
Medpace Holdings, Inc. Reports First Quarter 2024 Results
Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million, compared to $434.1 million for the comparable prior-year period.
April 22, 2024
·
17 min read
Business
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
Medpace Holdings, Inc. announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024.
March 28, 2024
·
1 min read
Business
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
Medpace Holdings, Inc. announced financial results for the fourth quarter and full year ended December 31, 2023.
February 12, 2024
·
18 min read
Press Releases
Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024
September 25, 2024
·
1 min read
Business
Medpace Holdings, Inc. Reports Third Quarter 2023 Results
Medpace Holdings, Inc. announced financial results for the third quarter ended September 30, 2023.
October 23, 2023
·
17 min read
1 of 69,877
Next
